PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Space Exploration Technologies Corporation, Hawthorne, CA, USA.\', \'Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.\', \'Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.\', \'Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Medicine, Harvard Medical School, Boston, MA, USA.\', \'Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.\', \'Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Microbiology, Harvard Medical School, Boston, MA, USA.\', \'Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.\', \'Brigham and Women\'s Hospital, Boston, MA, USA.\', \'Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/sciimmunol.abj2901
?:doi
?:hasPublicationType
?:journal
  • Science immunology
is ?:pmid of
?:pmid
?:pmid
  • 34652962
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all